Evidence-Based Dermatology: Research Commentary
September 2001

Sentinel Node Biopsy for Melanoma: What Is the Evidence?

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

Arch Dermatol. 2001;137(9):1228-1231. doi:10.1001/archderm.137.9.1228

Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous Melanoma

Blaheta H-J, Ellwanger U, Schittek B, Sotlar K, Maczey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C

J Invest Dermatol. 2000;114:637-642

Blaheta et al conducted a prospective cohort study on 116 patients with newly diagnosed primary cutaneous melanoma greater than or equal to 0.9 mm in Breslow depth. No patients showed evidence of metastatic disease and all underwent sentinel lymph node (SLN) biopsy.

First Page Preview View Large
First page PDF preview
First page PDF preview